Hypogonadism Suspended Phase 2 Trials for Alendronic acid (DB00630)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Suspended2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01460654Testosterone and Alendronate in Hypogonadal MenTreatment